A detailed history of Fortitude Family Office, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Fortitude Family Office, LLC holds 17 shares of UTHR stock, worth $7,183. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Previous 16 6.25%
Holding current value
$7,183
Previous $4.6 Million 55.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025

BUY
$274.7 - $438.75 $274 - $438
1 Added 6.25%
17 $7.13 Million
Q2 2025

Jul 14, 2025

BUY
$276.47 - $328.4 $4,423 - $5,254
16 New
16 $4.6 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $19.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Fortitude Family Office, LLC Portfolio

Follow Fortitude Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortitude Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortitude Family Office, LLC with notifications on news.